Pfizer’s Pricing Transparency Disclosures Are Out; The Company’s Net Prices Fell 2% Last Year
Shares:
It’s a big day for PDABs. Buckle up. *** The biggest news is probably Amgen’s suit against the state of Colorado that makes the case that the prescription drug affordability
It’s been a big week for commercials mocking PBMs as smug, suit-wearing jerks. Here’s PhRMA’s latest, positing that insurance companies are the same smug jerk as the PBMs, only with
Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv